<?xml version="1.0" encoding="UTF-8"?>
<p id="p0420">Multidrug-resistant influenza strains have been identified in immunocompromised patients. Triple-combination antiviral therapy with amantadine, ribavirin, and oseltamivir has been proposed to treat immunocompromised patients with severe influenza A with resistance to oseltamivir. A randomized trial comparing triple-combination antiviral therapy with oseltamivir alone in high-risk adults demonstrated an effect on viral outcomes but no clinical benefit.
 <xref rid="bib_44" ref-type="bibr">
  <sup>44</sup>
 </xref>
</p>
